Apparatus and Method for Testing Relationships Between Gene Expression and Physical Appearance of Skin

• US 20120034613A1
• Filed: 08/02/2011
• Published: 02/09/2012
• Est. Priority Date: 08/03/2010
• Status: Abandoned Application

• Current Assignee: NSE Products, Inc. (Nu Skin Enterprises Incorporated)
• Original Assignee: NSE Products, Inc. (Nu Skin Enterprises Incorporated)
• Inventors: Kern, Dale G., Gopaul, Remona, Lephart, Janet F.
• Application Number:
  US13/196,288
• Publication Number:
  US 20120034613A1
• Time in Patent Office: Days
• US Class Current: 435/6.12
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• CPC Class Codes: C12Q 1/6876 Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
• CPC Class Codes: C12Q 2600/158 Expression markers

Abstract

The disclosure is directed to apparatus and methods for testing relationships between gene expression and physical appearance of skin and methods of assessing the efficacy of skin anti-aging agents.

Claims

1. A method of testing to identify genes associated with one or more physical attributes of skin aging comprising:

exposing a first sample of human skin tissue to an agent;

determining a first set of expression levels of a plurality of genes in the first sample of human skin;

comparing the first set of expression levels to a second set of expression levels, the second set of expression levels corresponding to expression levels of human skin tissue not exposed to the agent, to identify a first subset of genes having a fold change difference in expression level between the exposed and unexposed samples that meets a first, selected biological relevance level;

selecting from the first subset of genes a second subset of genes, each gene being associated with a biochemical pathway associated with physical appearance of skin aging;

selecting from the second subset of genes, at least one skin attribute subset of genes, each gene in the skin attribute subset being associated with a biochemical pathway relating to the skin attribute that is shown in the comparing step to have been regulated in a more youthful direction for that biochemical pathway and skin attribute;

exposing a second sample of human skin tissue to the agent;

determining the levels of expression for the at least one skin attribute subset of genes in the second sample of human skin tissue using a method for determining expression levels that is different than that used for the first sample of human skin tissue; and

selecting a third subset of genes from the at least one skin attribute subset of genes whose expression levels in the second sample of human skin tissue meet a second, selected biological relevance level and whose direction of regulation conforms to the more youthful direction used in selecting the at least one skin attribute subset of genes.

2. The method of claim 1, wherein the biochemical pathway associated with the physical appearance of skin aging comprises at least one of skin structural protein synthesis, skin structural degradation and maintenance, extracellular matrix assembly, cellular differentiation, skin barrier component synthesis, skin barrier integrity, water regulation, or regulation of melanin production and control.

3. The method of claim 1, wherein the skin attribute for the at least one skin attribute subset of genes is skin structure, skin pigmentation, skin hydration or cell turnover.

4. The method of claim 1, wherein the first, selected biological relevance level is about a two fold difference between the exposed and unexposed samples.

5. The method of claim 1, wherein the human skin tissue comprises skin cells comprising at least one of keratinocytes, fibroblasts, adipocytes, melanocytes or combinations thereof.

6. The method of claim 1, wherein the first set of expression levels of a plurality of genes comprises expression levels for essentially the full human genome.

7. The method of claim 1, wherein the method for determining expression levels that is different than that used for the first sample of human tissue is a method using an RNA quantification metric.

8. The method of claim 1, wherein the step of selecting from the second subset of genes, at least one skin attribute subset of genes, each gene in the skin attribute subset being associated with a biochemical pathway relating to the skin attribute that is shown in the comparing step to have been regulated in a more youthful direction for that biochemical pathway and skin attribute comprising performing this step for a plurality of skin attribute subsets of genes;

and

the step selecting a third subset of genes from the at least one skin attribute subset of genes whose expression levels in the second sample of human skin tissue meet a second, selected biological relevance level and whose direction of regulation conforms to the more youthful direction used in selecting the at least one skin attribute subset of genes comprising performing this step for a plurality of skin attribute subsets of genes.

9. The method of claim 8, wherein the plurality of skin attribute subsets of genes are two or more skin attribute subset of genes selected from the group consisting of skin structure, skin pigmentation, skin hydration and cell turnover.

10. The method of claim 1 further comprising determining the levels of expression for additional genes associated with a biochemical pathway associated with skin aging in the second sample of human skin tissue using a method for determining expression levels that is different than that used for the first sample of human tissue;

and

selecting for the third subset of genes those genes from the additional genes associated with a biochemical pathway associated with skin aging whose expression levels in the second sample of human skin tissue meet a second, selected biological relevance level and whose direction of regulation conforms to the more youthful direction of regulation of the associated biochemical pathway.

11. A computer based system of testing to identify genes associated with one or more physical attributes of skin aging comprising:

a first instrument for exposing a first sample of human skin tissue to an agent and determining a first set of expression levels of a plurality of genes in the first sample of human skin;

a computer module for comparing the first set of expression levels to a second set of expression levels, the second set of expression levels corresponding to expression levels of human skin tissue not exposed to the agent to identify a first subset of genes having a fold change difference in expression level between the exposed and unexposed samples that meet a first, selected biological relevance level;

a computer module for accessing a stored data set identifying genes, each gene being associated with a biochemical pathway associated with physical appearance of skin aging and for selecting from the first subset a second subset comprising those genes also in the second subset;

a computer module for selecting from the second subset of genes, at least one skin attribute subset of genes, each gene in the skin attribute subset being associated with a biochemical pathway relating to the skin attribute that is shown in the comparing step to have been regulated in a more youthful direction for that biochemical pathway and skin attribute;

a second instrument for exposing a second sample of human skin tissue to the agent and for determining the levels of expression for the at least one skin attribute subset of genes in the second sample of human skin tissue using a method for determining expression levels that is different than that used for the first sample of human tissue; and

a computer module for selecting a third subset of genes from the at least one skin attribute subset of genes whose expression levels in the second sample of human skin tissue meet a second, selected biological relevance level and whose direction of regulation conforms to the more youthful direction used in selecting the at least one skin attribute subset of genes.

12. The system of claim 11, wherein the skin attribute for the at least one skin attribute subset of genes is skin structure, skin pigmentation, skin hydration or cell turnover.

13. The system of claim 11, wherein the first, selected biological relevance level is about a two fold difference between the exposed and unexposed samples.

14. The system of claim 11, wherein the human skin tissue comprises skin cells comprising at least one of keratinocytes, fibroblasts, adipocytes, melanocytes or combinations thereof.

15. The system of claim 11, wherein the first set of expression, levels of a plurality of genes comprises expression levels for essentially the full human genome.

16. The system of claim 11, wherein the second instrument for determining expression levels that is different than that used for the first sample of human tissue is an instrument using an RNA quantification metric.

17. A method of assessing the efficacy of a skin anti-aging agent comprising:

exposing a first sample of human skin tissue to an agent;

determining a first set of expression levels of a plurality of genes in the first sample of human skin;

comparing the first set of expression levels to a second set of expression levels, the second set of expression levels corresponding to expression levels of human skin tissue not exposed to the agent, to identify a first subset of genes having a fold change difference in expression level between the exposed and unexposed samples that meets a first, selected biological relevance level;

selecting from the first subset of genes a second subset of genes, each gene being associated with a biochemical pathway associated with physical appearance of skin aging;

selecting from the second subset of genes, at least one skin attribute subset of genes, each gene in the skin attribute subset being associated with a biochemical pathway relating to the skin attribute that is shown in the comparing step to have been regulated in a more youthful direction for that biochemical pathway and skin attribute;

exposing a second sample of human skin tissue to the agent;

determining the levels of expression for the at least one skin attribute subset of genes in the second sample of human skin tissue using a method for determining expression levels that is different than that used for the first sample of human skin tissue;

selecting a third subset of genes from the at least one skin attribute subset of genes whose expression levels in the second sample of human skin tissue meet a second, selected biological relevance level and whose direction of regulation conforms to the more youthful direction used in selecting the at least one skin attribute subset of genes; and

comparing the third subset of genes to a previously determined third subset of genes for a second agent, thereby showing the efficacy of the skin anti-aging agent.

18. The method of claim 17, wherein the skin attribute for the at least one skin attribute subset of genes is skin structure, skin pigmentation, skin hydration or cell turnover.

19. The method of claim 17, wherein the method for determining expression levels that is different than that used for the first sample of human tissue is a method using an RNA quantification metric.

20. A method of formulating a composition with a plurality of skin anti-aging agents, comprising:

assessing the efficacy of each of two or more skin anti-aging agents by a method comprising;

exposing a first sample of human skin tissue to an agent;

determining a first set of expression levels of a plurality of genes in the first sample of human skin;

comparing the first set of expression levels to a second set of expression levels, the second set of expression levels corresponding to expression levels of human skin tissue not exposed to the agent, to identify a first subset of genes having a fold change difference in expression level between the exposed and unexposed samples that meets a first, selected biological relevance level;

selecting from the first subset of genes a second subset of genes, each gene being associated with a biochemical pathway associated with physical appearance of skin aging;

selecting from the second subset of genes, at least one skin attribute subset of genes, each gene in the skin attribute subset being associated with a biochemical pathway relating to the skin attribute that is shown in the comparing step to have been regulated in a more youthful direction for that biochemical pathway and skin attribute;

exposing a second sample of human skin tissue to the agent;

determining the levels of expression for the at least one skin attribute subset of genes in the second sample of human skin tissue using a method for determining expression levels that is different than that used for the first sample of human skin tissue;

selecting a third subset of genes from the at least one skin attribute subset of genes whose expression levels in the second sample of human skin tissue meet a second, selected biological relevance level and whose direction of regulation conforms to the more youthful direction used in selecting the at least one skin attribute subset of genes; and

comparing the third subset of genes to a previously determined third subset of genes for a second agent, thereby showing the efficacy of the skin anti-aging agent;

selecting from the two or more skin anti-aging agents assessed two or more agents found to have efficacy for at least one skin attribute; and

formulating a composition with such two or more agents found to have efficacy as active ingredients and a pharmaceutically acceptable carrier.

21. The method of claim 20, wherein the skin attribute for the at least one skin attribute subset of genes is skin structure, skin pigmentation, skin hydration or cell turnover and the composition is directed to regulation of the genes in the at least one skin attribute subset of genes in a more youthful direction.

22. The method of claim 20, wherein the method for determining expression levels that is different than that used for the first sample of human tissue is a method using an RNA quantification metric.